Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Diagnostics » Juergen Schwiezer, Severin Schwan, Franz Humer, David Lester, Michael Mullenix, Gabriella Szekely-Klepser

Juergen Schwiezer, Severin Schwan, Franz Humer, David Lester, Michael Mullenix, Gabriella Szekely-Klepser

Oct 10, 2007
Premium
Jürgen Schwiezer will become CEO of Roche Diagnostics on Jan. 1, 2008. He will succeed Severin Schwan, who will take over the role of CEO of the Roche Group from Franz Humer in March.
 
Schwiezer is currently president of the Europe, Middle East, and Africa regions for Roche Diagnostics. He joined Boehringer Mannheim in 1976 and held a number of management positions in marketing and sales. That firm was acquired by Roche in 1997.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

NSF's Investigations

Nature News reports on the US National Science Foundation's investigations of undisclosed foreign ties among researchers it funds.

OK, So Who Is Here?

Researchers have developed a set of 10 principles to guide how a list of all species on earth should be put together, the Guardian reports.

Write It In

Wired reports on a new firm developing a gene writing approach for therapeutic genome changes.

Nature Presents Approach to Uncover Regulatory Noncoding Variants in Cancer, More

In Nature this week: a method called cis-X combines whole-genome and transcriptome sequencing data to identify regulatory noncoding variants, and more.

Jul
14
Featured Webinar

Development of a Metagenomics-based Pathogen-Detection Assay for SARS-CoV-2 Research

Sponsored by
Agilent

This webinar will describe a rapid metagenomics assay under development for human pathogens, including the SARS-CoV-2 coronavirus.

Jul
15
Featured Webinar

Diagnostic Challenges in Cancer Immunotherapy: An Expert Panel Discussion

Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.

Jul
22
Featured Webinar

Advances in Genetic Testing for IVF Research: PGT-A, PGT-M, and Carrier Screening

Sponsored by
Thermo Fisher Scientific

Luis A. Alcaraz, cofounder of Bioarray and Journey Genomics, accredited diagnostic and research labs based in Alicante, Spain, will review how his teams use advanced genomic techniques for carrier screening research as well as for preimplantation genetic testing (PGT) in embryos for both aneuploidies (PGT-A) and monogenic disorders (PGT-M).

Jul
23
Featured Webinar

Clinical Utility of Liquid Biopsy for the Detection of T790M to Guide Lung Cancer Treatment Strategy

Sponsored by
Roche

This webinar will discuss a study that set to assess the efficacy and safety of osimertinib in EGFR T790M positive non-small cell lung cancer (NSCLC) patients identified by using plasma sample and cobas EGFR Mutation test v2. This is the first prospective study to use liquid biopsy upfront to evaluate osimertinib efficacy.

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.